Find Academic Supervisors

Nishant K. TView profile

Professor

• Genome Stability
• Meiotic Recombination
• Mitotic Genome Stability
• +3 more

Nishant K.T is a Professor in the School of Biology at the Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, where he has served as Professor since 2022, Associate Professor from 2017-2022, and Assistant Professor from 2011-2017. He also served as Head of the School of Biology from 2017-2021. Prior to joining IISER-TVM, he was a Research Associate and Postdoctoral Fellow at Cornell University, USA (2005-2010). Ph.D from Dept. of Biochemistry, Indian Institute of Science, Bangalore (2005) M.S in Biological Sciences from Indian Institute of Science, Bangalore (2000) B.Sc(H) in Biochemistry from Sri Venkateswara College, Delhi University (1997) Dr. Nishant's research focuses on mechanisms that maintain genome stability using baker's yeast Saccharomyces cerevisiae as a model system. His laboratory investigates two key areas: mechanisms of meiotic recombination, with emphasis on meiotic crossover pathways and their role in promoting accurate chromosome segregation during meiosis (errors linked to congenital birth defects like Down syndrome); and mechanisms of mitotic genome stability, studying processes contributing to mutagenesis, loss of heterozygosity and aneuploidy using high-throughput genomic technologies, classical genetics and molecular biology approaches. His work has significant implications for understanding disease progression (e.g., cancer), genome evolution and architecture. Analysis of Dr. Nishant's recent publications (2017-2025) reveals a consistent focus on yeast genetics and genome stability, with particular emphasis on meiotic recombination mechanisms, chromosome segregation, and DNA repair pathways. His work often employs high-throughput genomic approaches to study loss of heterozygosity, crossover formation, and chromosome dynamics in both meiotic and mitotic contexts. The research spans fundamental mechanisms with implications for human health conditions including cancer and congenital disorders. Scientific Awards and Editorial Positions Wellcome Trust-DBT Intermediate Fellow (2012-2017) Editorial board member of the journal YEAST (2021-present) Guest Editor for a special issue of the journal YEAST (2020) Editorial board member for Journal of Genetics (2018-present) Visiting Professor, Osaka University (2018) Visiting scientist, Osaka University, DST-JSPS exploratory exchange (2014) Best Poster awards at Society of Biological Chemists (India) meetings (2001, 2003) CSIR Research Fellowships (Junior 2001-2002, Senior 2002-2004) Dr. Nishant has mentored numerous students through IISER-TVM's PhD and Integrated PhD programs, with several alumni now holding independent research positions. His laboratory (GSL Lab) maintains an active research program with current PhD students working on bioinformatics, yeast genetics, and chromosome stability projects. He has co-organized multiple International Chromosome Stability meetings at various locations in India (Trivandrum 2012, 2016, 2022; Bangalore 2014, 2018, 2024), demonstrating leadership in the field. The GSL Lab operates as a dynamic research team using Saccharomyces cerevisiae as a model system, combining high-throughput genomic technologies with classical genetics and molecular biology approaches. Current lab members include PhD students, postdoctoral researchers, and undergraduate students working collaboratively on projects related to genome stability mechanisms.

• Forensic Medicine
• Pediatric Pathology
• Postmortem Analysis
• +4 more

Klaus Püschel is a Professor at the Institute of Forensic Medicine, University Medical Center Hamburg-Eppendorf (UKE). His research focuses on Forensic Pediatrics Skeletal Regeneration in Orthopedics Postmortem Analysis of Trauma Osteoporotic Bone Pathology Medico-Legal Death Classification Research Trends: His publications emphasize forensic case studies, particularly in pediatric deaths from traffic accidents, drowning, and historical exhumations. He investigates cement leakage in spinal procedures and allograft integration in revision surgeries. Key Publications: Recent works include analyses of 3-year-old drowning cases , 60-year exhumation studies , and osteoporotic vertebral augmentation complications .

Ann E. SutherlandView profile

Associate Professor

• Cell Biology
• Developmental Biology
• Embryology
• +4 more

Ann E. Sutherland is an Associate Professor in the Department of Cell Biology at the University of Virginia School of Medicine. Her research focuses on cellular mechanisms of embryonic development, particularly in mouse models. Education: BA in Biology from Wellesley College PhD in Anatomy from the University of California San Francisco Sutherland's research program investigates cell behavior and morphogenesis during early mouse development , with emphasis on two key areas: the cellular mechanisms of implantation and gastrulation in the mouse embryo. Her laboratory employs genetic, cell biological, and live imaging approaches to understand the morphogenesis of the early mouse embryo. Specific research questions include understanding the cellular mechanisms underlying elongation of the primary axis of the embryo, as well as the interactions between the embryo and mother that promote and pattern the formation of the placenta. Analysis of her publication record spanning from 2010 to 2024 reveals consistent focus on developmental biology, particularly in the areas of cell morphogenesis, embryonic axis formation, and implantation mechanisms. Her work demonstrates expertise in live imaging techniques, genetic approaches, and cell biological analyses of mouse embryonic development. Key themes across her publications include planar cell polarity signaling, convergent extension processes, trophoblast cell behavior, and the role of specific proteins in embryonic patterning. Collaborations: Dr. Xiaowei Lu (Cell Biology, UVA) Dr. Ray Keller (Biology, UVA) Dr. Ammasi Periasamy (Keck Center for Cellular Imaging) Dr. Carol Burdsal (Bucknell University) Sutherland maintains an active laboratory (Sutherland Lab) focused on developmental biology research, with ongoing projects examining amino acid signaling in embryo implantation, extracellular matrix effects on trophoblast behavior, and cell behaviors during gastrulation. Her work combines advanced imaging techniques with genetic approaches to unravel the cellular mechanisms underlying early mammalian development.

Sharon E PlonView profile

Professor

• Cancer Genetics
• Clinical Genomics
• Pediatric Oncology
• +2 more

Sharon E Plon, M.D., Ph.D., is a Professor at Baylor College of Medicine in the Department of Molecular and Human Genetics. She holds additional roles as Co-Leader of the Pediatric Cancer Program at the Dan L. Duncan Comprehensive Cancer Center and Director of the Cancer Genetics Clinical and Research Programs at Texas Children's Hospital. Her research focuses on cancer genetics and clinical genomics , particularly in understanding genetic susceptibility to pediatric cancers through collaborative projects like the NHGRI/NCI-funded Texas KidsCanSeq trial. Keywords: Genetics, Pediatrics, Oncology, Precision Medicine Notable Projects: Whole-genome sequencing for novel cancer susceptibility genes, ClinGen international initiative Scientific Awards: Fellow, American College of Medical Genetics and Genomics (06/1995) Advising and Grants: Co-PI of the Texas KidsCanSeq trial (NHGRI/NCI U01 grant) and principal investigator for ClinGen, an international project to define clinical relevance of genes and variants.

Lihong QiView profile

Professor

• Biostatistics
• Epidemiology
• Genetic Association Studies
• +3 more

Lihong Qi is a Professor in the Department of Public Health Sciences at the University of California, Davis. Her research focuses on biostatistical methods applied to genetic association studies, complex traits (including cancer), survival analysis, and modeling missing data. She has contributed to studies on dietary energy density's role in cancer, environmental pollution's cardiovascular effects, and congenital anomalies like bladder exstrophy. Ph.D. in Biostatistics, University of Washington (2003) M.S. in Biostatistics, University of Washington (2000) M.S. in Statistics, Florida State University (1998) M.S. in Applied Mathematics, Peking University (1996) Her work integrates advanced statistical techniques to address public health challenges, particularly in epidemiology and genetic research. Her publications span journals in biostatistics, molecular medicine, and environmental health, reflecting interdisciplinary collaboration. No scientific awards listed. Her research has been supported by grants focusing on genetic epidemiology and environmental health studies. She has advised on studies involving bladder exstrophy, obesity-related cancers, and air pollution impacts. Her lab focuses on statistical methodologies for healthcare and genetic disorders.

Mollie E. WoodView profile

Assistant Professor

• Reproductive/Perinatal Epidemiology
• Pharmacoepidemiology
• Epidemiologic Methods
• +3 more

Mollie E. Wood, PhD, MPH is an Assistant Professor in the Department of Epidemiology at the University of North Carolina's Gillings School of Global Public Health. Her research focuses on medication safety during pregnancy, particularly for chronic conditions like depression, migraine, and diabetes. She holds a PhD in Clinical and Population Health from the University of Massachusetts Medical School (2015), an MPH in Epidemiology from Boston University (2009), and a BA in Zoology/Psychology from Miami University (2004). Dr. Wood's work bridges reproductive/perinatal epidemiology, pharmacoepidemiology, and epidemiologic methods. She examines how healthcare policies and practices influence maternal and child health outcomes, with recent studies addressing midwifery access, contraceptive use trends, and neurodevelopmental effects of prenatal drug exposures. Her methodological innovations include improving pregnancy cohort identification in insurance claims and addressing structural racism in health intervention evaluations. Her research has been published in high-impact journals, emphasizing rigorous epidemiologic methods and real-world data applications. She collaborates across disciplines to advance evidence-based practices in perinatal health and reduce healthcare disparities.

Maria Teresa Grønning DaleView profile

Associate Professor

• Quantitative Methods
• Trauma and Disasters
• Prenatal Risk Factors
• +2 more

Maria Teresa Grønning Dale is an Associate Professor at the University of Oslo's Department of Psychology, affiliated with the Methodology, Work, Cultural and Social Psychology division. She holds dual roles as a researcher at the Norwegian Centre for Violence and Traumatic Stress Studies (NKVTS) and an Associate Professor II/Lecturer in the Psychology Department. Her academic journey includes a PhD from the National Institute of Public Health (2009-2012) and postdoctoral research there until 2018. Research Interests: Her work focuses on quantitative methods, trauma and disasters, prenatal risk factors, positive psychology, and personality psychology. Key projects include studies on workplace trauma, maternal health outcomes, and the psychological impacts of terrorism and congenital heart defects. Publications: Dr. Dale's research spans epidemiological studies, longitudinal cohort analyses, and clinical psychology. Recent work examines childhood trauma and adult revictimization (2025), post-terrorist attack psychosocial factors (2021), and prenatal dietary impacts on birth outcomes (2019). Her earlier studies (2011-2013) explored maternal well-being in families with congenital heart defects. Affiliations: She teaches courses like PSY1010 (Methodology) and PSY4020 (Quantitative Research Methods). Her research collaborations include NKVTS and the National Institute of Public Health. Professional experience includes roles in HR consulting and Red Cross leadership. Labs/Teams: Active in NKVTS trauma research and affiliated with the Psychology Department's quantitative methodology group.

Terence OzolinsView profile

Associate Professor

• Developmental Toxicology
• Cardiac Birth Defects
• Ventricular Septation
• +2 more

Terence Ozolins is an Associate Professor in the Department of Biomedical and Molecular Sciences at Queen's University's Faculty of Health Sciences. He holds cross-appointments with the Translational Institute of Medicine (TIME) and teaches courses in pharmacology and toxicology, including PHAR 480: Drug Discovery and Development. His research focuses on the etiology of ventricular septation defects (VSD) using rat models to understand how environmental influences during gestation cause structural heart defects and long-term postnatal cardiac dysfunction even after spontaneous repair. The lab investigates molecular mechanisms underlying teratogen-induced cardiac malformations and persistent physiological abnormalities. Publications demonstrate expertise in high-resolution fetal ultrasound imaging, molecular pathways of teratogenesis, and transgenerational effects of chemical exposures. Recent work explores AP-1 transcription factor regulation in embryotoxicity. Scientific Awards: Safety Sciences Award for Scientific Excellence (2003) Dr. Ozolins maintains collaborations with clinical researchers and previously spent 11 years in pharmaceutical industry research. Current projects examine epigenetic mechanisms in congenital heart defects and developmental origins of adult cardiovascular disease.

• Developmental Biology
• Genetics
• Pediatrics
• +3 more

Mustafa Khokha, MD, is an Adjunct Professor in the Department of Pediatrics at Yale School of Medicine. His research focuses on understanding the molecular mechanisms underlying congenital malformations and critical illnesses in infants using genetic sequencing and Xenopus tropicalis as a model system. He directs the Pediatric Genomics Discovery Program (PGDP), which identifies genetic causes of undiagnosed diseases in children. Khokha’s work bridges clinical care and research, aiming to translate genetic discoveries into improved patient outcomes. Education: MD from Northwestern University Medical School (1995), BS from Northwestern University (1991), Residency in Pediatrics at St. Louis Children's Hospital (1995–98), Fellowship in Pediatric Critical Care at University of California, San Francisco (2002), and Fellowship in Molecular & Cell Biology at University of California, Berkeley (2006). His research integrates developmental biology and genetics to study embryonic patterning defects, particularly in congenital heart disease and facial malformations. Using high-throughput screens in Xenopus, he identifies genes responsible for birth defects and elucidates their functional roles. Key achievements include discovering the role of GALNT11 in laterality and cilia function, and linking CACNA1G to left-right patterning. His work on β-catenin nuclear transport and Wnt signaling has advanced understanding of developmental pathways. Awards: Mallinckrodt Scholar (2014), Mae Gailani Junior Faculty Teaching Award (2010), Harvey Colten Award (2009). Labs/Teams: Khokha Lab, part of the Program in Translational Biomedicine and the Yale Center for Genomic Health. Collaborations include the Pediatric Critical Care Transport Program and the Yale Medicine team.

• Preeclampsia
• Prenatal Ultrasound
• Fetal Hemodynamics
• +3 more

Tulin Ozcan, MD is an Associate Professor of Obstetrics, Gynecology and Reproductive Sciences at Yale University School of Medicine. She joined the Maternal Fetal Medicine faculty at Yale University in September 2023, bringing extensive experience in high-risk pregnancies and prenatal imaging. Dr. Ozcan completed her medical education and residency in Obstetrics and Gynecology in Ankara, Turkey. She then pursued research fellowships at Utrecht University in the Netherlands and Yale University. She also conducted bench research at the Department of Molecular Biology and Genetics at Yale University. After completing her maternal fetal medicine fellowship at Yale University, she practiced as faculty at the University of Rochester, Fetal Center at CHOP, and University Hospitals Cleveland Medical Center before returning to Yale. Dr. Ozcan's clinical and research interests center around high-risk pregnancies, with a special focus on preeclampsia, prenatal ultrasound, assessment of fetal hemodynamics using Doppler technology, and maternal and fetal issues unique to multiple pregnancies. She has a strong background and experience in fetal echocardiography and advanced ultrasound. Her work bridges clinical practice with research to improve outcomes for mothers and babies in complex pregnancy scenarios. Her recent publications demonstrate a consistent focus on prenatal diagnosis, fetal imaging, and management of high-risk pregnancies. Key areas of her research include placental vascular issues, congenital anomalies, twin pregnancies, and ultrasound techniques for fetal assessment. Dr. Ozcan's work often involves collaborative research across institutions, as evidenced by her participation in the North American Fetal Therapy Network studies. Dr. Ozcan is committed to patient-centered care, emphasizing honesty and realistic information sharing while working as a team with expectant mothers facing challenging pregnancies. She treats a variety of conditions including gestational diabetes, preeclampsia, and placental previa, always focusing on the dual care of mother and fetus that characterizes maternal-fetal medicine.

• Medicines Management
• Adverse Drug Reactions
• Nursing Pharmacology
• +4 more

Professor Sue Jordan is a leading academic in medicines management and health services research at Swansea University's School of Health and Social Care. Her work focuses on improving patient safety through nurse-led adverse drug reaction (ADRe) profiles, which identify and mitigate risks associated with prescription medications. Her current project, the ADRe Profile, aims to reduce medicine-related harm in older adults and optimize dosing to minimize adverse effects like sedation and falls. Her research has influenced UK breastfeeding guidelines by advocating for lower labor medication doses and exploring antidepressants' impact on infant outcomes through European collaborations. Her career highlights include influencing national healthcare policies, leading international studies on congenital anomalies and medication safety, and contributing to nursing education standards in pharmaceutical care. She collaborates with organizations like the EUROmediCAT and ConcePTION consortia to advance drug safety during pregnancy and breastfeeding. Publications emphasize systematic reviews on ADR identification methods, probiotic impacts on infant microbiota, and cross-European analyses of medication use in congenital anomaly cohorts. Her work bridges clinical practice and policy, emphasizing interprofessional collaboration in pharmaceutical care.

Stefaan VerbruggenView profile

Lecturer

• Bone biomechanics
• Cancer mechanobiology
• Developmental biomechanics
• +4 more

Dr. Stefaan Verbruggen is a Lecturer in Medical Technology at Queen Mary University of London (QMUL), affiliated with the School of Engineering and Materials Science and the Centre for Bioengineering. He holds a BEng and PhD from the National University of Ireland Galway and is a Fellow of the Higher Education Academy. His research focuses on bone mechanobiology, cancer metastasis, and organ-on-a-chip technologies. As a Visiting Academic at the INSIGNEO Institute for in silico Medicine, he develops computational models of metastatic bone lesions. Prior roles include postdoctoral research at Imperial College London and a Marie Sklodowska-Curie Research Fellowship at QMUL. He collaborates extensively with institutions like Columbia University. Research interests include bone cell mechanobiology, developmental biomechanics, and predictive in vitro models for cancer. Key projects involve modeling fetal movement effects on joint development and elucidating how mechanical forces influence cancer cell behavior. He leads grants totaling over £1.8M, including initiatives to reduce animal testing via organ-on-a-chip platforms. Awards include the Marie Curie Fellowship and the European Society of Biomechanics’ S.M. Perren Award (2018). Teaching roles include organizing modules in medical imaging and biomedical engineering. His work spans interdisciplinary collaborations in oncology, biomechanics, and tissue engineering, with a focus on translating computational insights into clinical applications.

Kevin A. HenryView profile

Professor

• Health Geography
• Geographic Information Systems (GIS)
• Epidemiology
• +12 more

Kevin A. Henry is a Professor and Department Chair in the Department of Geography, Environment, and Urban Studies at Temple University's College of Liberal Arts. He is also an affiliated faculty member with the Global Studies program and the Center for Sustainable Communities. Additionally, he is a member of the Cancer Prevention and Control program at Fox Chase Cancer Center. His educational background includes a Ph.D. in Geography from McGill University (2005) and a postdoctoral fellowship in biostatistics and epidemiology at the same institution. Dr. Henry's research is centered on health geography, with a focus on geospatial analysis methods to study cancer prevention, patient outcomes, and health disparities. His expertise includes spatial statistics, disease mapping, GIS, epidemiology, and life-course perspectives on health. He investigates geographic access to healthcare, particularly cancer screening and treatment, and integrates residential histories into cancer research. His work employs advanced geospatial methods to understand how place influences health outcomes. The recent publications reflect a strong trend in spatial epidemiology, cancer disparities, and geospatial modeling. Key themes include HPV vaccination disparities across rural-urban gradients, socioeconomic and geographic determinants of cancer incidence and stage at diagnosis, and the application of GIS to public health and environmental health. The articles demonstrate interdisciplinary collaboration and a consistent focus on using spatial analytics for health policy and cancer control. Dr. Henry has received research funding from major national agencies including the National Science Foundation (NSF), National Institutes of Health (NIH), Department of Defense (DOD), and American Cancer Society (ACS). He serves on advisory committees and collaborates with the National Cancer Institute (NCI), Centers for Disease Control and Prevention (CDC), and North American Association of Central Cancer Registries (NAACCR). He mentors students through the Medical Geography and Population Health Spatial Analytics Laboratory (MAPS Lab), where he supervises graduate and undergraduate research in medical geography. He has taught courses such as Fundamentals of GIS, Health and Medical Geography, GIS for Public Health, Spatial Epidemiology, and Environmental GIS. He is actively recruiting PhD students (starting Fall 2026) and postdoctoral researchers for NIH- and DOD-funded projects. The MAPS Lab conducts applied research using spatial analysis and statistical methods to examine geographic accessibility and place-based health disparities. The lab emphasizes the role of geographic factors in health outcomes, particularly in cancer prevention and care, and engages in interdisciplinary collaborations and national data initiatives.

Eve RomanView profile

Professor

• Cancer Epidemiology
• Haematological Malignancies
• Childhood Cancer
• +3 more

Eve Roman is a Professor in Epidemiology and Cancer Statistics at the University of York's Department of Health Sciences. She co-founded the Haematological Malignancy Research Network (HMRN) in 2004, which utilizes NHS infrastructure to track 38,000 blood cancer patients for clinical and research purposes. Her work focuses on cancer epidemiology with a specific interest in haematological malignancies and childhood cancer using population-based data. Education : BSc in Applied Biology, Brunel University PhD in Epidemiology, London School of Hygiene & Tropical Medicine Her research explores epidemiological study design and routinely collected health data to analyze risk factors like maternal health and adverse reproductive outcomes. She has contributed to major projects such as the UK Childhood Cancer Study (UKCCS) and European Myelodysplastic Syndromes Registry (EUMDS) , emphasizing real-world data for informed clinical decisions. Recent publications highlight her work on chronic blood cancer patient experiences (2024), maternal pregnancy exposures and childhood cancer (2024), and genetic subtypes in lymphoma (2022). These studies demonstrate her expertise in qualitative research methods and genetic epidemiology . Scientific awards include: Editor-in-Chief of Cancer Epidemiology (Elsevier) Honorary Visiting Professor at the London School of Hygiene and Tropical Medicine Member of the Childhood Leukaemia International Consortium (CLIC) Contributor to the International Lymphoma Epidemiology Consortium (InterLymph) She supervises PhD and Master’s students in haematological malignancy epidemiology and teaches undergraduate modules like Understanding Health and Disease . Her external roles involve advisory positions on the Yorkshire and Humber Haematology Cancer Network and the UKCCS Research Committee .

• Reproductive Endocrinology and Infertility
• Embryo Implantation
• Stem Cell Biology
• +9 more

Reshef Tal, MD, PhD, is Associate Professor of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine. He is a physician-scientist and reproductive endocrinologist specializing in infertility, IVF, PCOS, recurrent pregnancy loss, and endometrial disorders. He leads an NIH R01-funded laboratory and is affiliated with the Fertility Center, Endometriosis Program, and the Janeway Society at Yale. Medical Degree: Sackler School of Medicine, Tel-Aviv University (2009) PhD in Molecular Biology: Tel-Aviv University (2009) Postdoctoral Fellowship: Lunenfeld Research Institute, University of Toronto Residency: Maimonides Medical Center, NY Fellowship: Reproductive Endocrinology and Infertility, Yale University School of Medicine Board Certification: American Board of Obstetrics & Gynecology Dr. Tal’s research focuses on the role of mesenchymal stem cells and immune cells in embryo implantation, uterine remodeling, and pregnancy maintenance. His work aims to develop novel regenerative therapies for infertility. Key areas include CXCR4 signaling, bone marrow-derived cell recruitment, and endometrial regeneration. He has published over 70 peer-reviewed articles and edited a book on Anti-Müllerian Hormone. His recent publications highlight themes in reproductive immunology, stem cell biology, and the molecular basis of PCOS and endometriosis. Trends include the use of genetic and mouse models to dissect pathways in implantation failure and placental development, with translational applications in IVF and regenerative medicine. Scientific awards include: Society for Reproductive Investigation (SRI) President's Plenary Award Albert S. McKern Award K12 Women’s Reproductive Health Research (WRHR) Career Development Award ASRM Research Grant Patterson Trust Fellowship New England Fertility Society/Ferring Fellow Research Award SREI/ASRM Fellow Research Award Dr. Tal has secured NIH RO1 funding and is involved in multiple clinical trials, including studies on stem cell mobilization for Asherman’s syndrome and green tea compounds for fibroids. He mentors junior researchers and collaborates with leaders such as Hugh Taylor and David Seifer. He serves as Associate Editor for Reproductive Biology & Endocrinology and is part of the Yale WRHR Advisory Committee. His lab, the Tal Lab, is central to advancing regenerative approaches in reproductive medicine. He is actively engaged in patient care and research at Yale Medicine and Yale Ventures, contributing to innovation in fertility preservation and IVF programs.